Response and Survival Associated with First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

Giampaolo Perri, Laura Prakash, Wei Qiao, Gauri R. Varadhachary, Robert Wolff, David Fogelman, Michael Overman, Shubham Pant, Milind Javle, Eugene J. Koay, Joseph Herman, Michael Kim, Naruhiko Ikoma, Ching Wei Tzeng, Jeffrey E. Lee, Matthew H.G. Katz

Research output: Contribution to journal › Article › peer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Response and Survival Associated with First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences